Company: ABBV
Filing Date: 2025-06-13
Form Type: 11-K
Source: 0001104659-25-059360
Chunk: 11

Company: AbbVie Inc.
Filing Date: 2025-06-13
Form: 11-K
Chunk 11
---
 assets available for benefits as net
appreciation in fair value of investments.

Payment of Benefits

Benefits are recorded when paid.

<div align='center'>12</div>

AbbVie Savings Plan

NOTES TO FINANCIAL STATEMENTS - CONTINUED

December 31, 2024 and 2023

NOTE C - INVESTMENTS

A summary of AbbVie common share data as of December 31, is presented
below:

|                                                                                              |     |   |      2024 |     |   |      2023 |
|:---------------------------------------------------------------------------------------------|:----|:--|----------:|:----|:--|----------:|
| AbbVie common shares, 12,340,181 and 12,728,885 shares, respectively, (dollars in thousands) |     | $ | 2,192,850 |     | $ | 1,972,595 |
| Market value per share                                                                       |     | $ |    177.70 |     | $ |    154.97 |

In general, the investments provided
by the Plan are exposed to various risks, such as interest rate, credit and overall market volatility risks. Due to the level of risk
associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur
in the near term and that such changes could materially affect participant accounts and the amounts reported in the statements of net
assets available for benefits.

NOTE D - RELATED-PARTY AND PARTY-IN-INTEREST TRANSACTIONS

The Plan invests in the common stock of
AbbVie. These transactions qualify as party-in-interest transactions; however, they are exempt from the prohibited transaction rules under
ERISA. During 2024, the Plan received $77.6 million in common stock dividends from AbbVie.

Participants pay fees to the recordkeeper
for loan and withdrawal transaction processing and also pay commissions on purchases and sales of AbbVie shares and sales of Abbott stock.
These transactions qualify as permitted party-in-interest transactions.

NOTE E - PLAN TERMINATION

The Plan may be terminated or contributions
discontinued at any time by AbbVie upon written notice to the Trustee and the Committee. All participants’ account balances are
fully vested upon Plan termination. Upon termination of the Plan, distributions of each participant’s share in the Trust, as determined
by the terms of the Plan, will be made to each participant. At the present time, AbbVie has